Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2012
05/08/2012US8173617 RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
05/08/2012US8173616 RNA-induced translational silencing and cellular apoptosis
05/08/2012US8173615 TRPM-2 antisense therapy
05/08/2012US8173614 Therapeuting compositions comprising an RNAi agent and a neurotrophic factor and methods of use thereof
05/08/2012US8173613 Modulation of mesenchymal and metastatic cell growth
05/08/2012US8173611 Methods and compositions involving miRNA and miRNA inhibitor molecules
05/08/2012US8173602 Detecting CYP24 expression level as a marker for predisposition to cancer
05/08/2012US8173590 AXMI-004, a delta-endotoxin gene and methods for its use
05/08/2012US8173429 Characterization of the I-Spomi endonuclease from fission yeast
05/08/2012US8173428 LNA oligonucleotides and the treatment of cancer
05/08/2012US8173424 Internalizing ErbB2 antibodies
05/08/2012US8173423 Diagnosis and treatment of T-cell acute lymphoblastic leukemia
05/08/2012US8173422 Method for improving protein production
05/08/2012US8173416 Circuit arrangement for injecting nucleic acids and other biologically active molecules into the nucleus of higher eucaryotic cells using electrical current
05/08/2012US8173410 Isoprene synthase variants for improved microbial production of isoprene
05/08/2012US8173409 Acid fungal proteases
05/08/2012US8173408 Recombinant carrier molecule for expression, delivery and purification of target polypeptides
05/08/2012US8173402 Modified yeasts and uses thereof, in particular for producing steroid derivatives
05/08/2012US8173397 Folded recombinant catalytic fragments of multidomain serine proteases, preparation and uses thereof
05/08/2012US8173396 Methods for reducing gluconoylation of proteins
05/08/2012US8173395 Mussel bioadhesive
05/08/2012US8173393 Expanding the eukaryotic genetic code
05/08/2012US8173392 In vivo incorporation of unnatural amino acids
05/08/2012US8173387 Method of examining chemical using gene-disrupted strain
05/08/2012US8173378 Methods of using an alpha-1-adrenergic receptor having altered ligand affinity
05/08/2012US8173377 Methods and compositions for determining the purity of chemically synthesized nucleic acids
05/08/2012US8173364 Methods and composition for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs
05/08/2012US8173363 Random transposon insertion in Staphylococcus aureus and use thereof to identify essential genes
05/08/2012US8173170 The carrier is bound to a retinoid derivative such as vitamin A or encapsulated with the drug, such as a siRNA against collagen-specific HSP47, in a liposome or micelle and then delivered specifically to astrocytes while minimizing side effects; cirrhosis, liver and pancreatic cancers
05/08/2012US8173134 ECD carboxy-terminal deletion FGFR4 fusion proteins and methods of producing them
05/08/2012US8173124 Method to treat using antagonistic anti-hTNFSF13b human antibodies
05/08/2012US8173117 Mouse CX3C chemokine polypeptides
05/08/2012CA2623339C Virulence genes in the vgc2 cluster of salmonella
05/08/2012CA2555489C Method of converting base in dna sequence
05/08/2012CA2533338C Viral vectors
05/08/2012CA2520636C Variant humicola grisea cbh1.1
05/08/2012CA2520541C Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field
05/08/2012CA2498668C Generation of plants with improved drought tolerance
05/08/2012CA2492153C Production of polyketide fkbp-ligand analogues
05/08/2012CA2421447C Collections of repeat proteins comprising repeat modules
05/08/2012CA2411842C A protein fragment complementation assay utilizing e.coli tem-1 .beta.-lactamase
05/08/2012CA2388041C High mannose proteins and methods of making high mannose proteins
05/08/2012CA2348367C Transgenic plant expressing maltogenic alpha-amylase
05/08/2012CA2340593C Use of vegf-c or vegf-d gene or protein to prevent restenosis
05/08/2012CA2325350C Microbial strains and processes for the manufacture of biomaterials
05/08/2012CA2284271C A preventive or therapeutic agent for sensitized t cell-mediated diseases comprising il-6 antagonist as an active ingredient
05/08/2012CA2229741C Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
05/08/2012CA2163211C Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
05/08/2012CA1341629C Hepatitis c diagnostics and vaccines
05/07/2012CA2850863A1 Pharmaceutical composition comprising l-dna
05/03/2012WO2012058642A2 Use of sam68 for modulating signaling through the tnf receptor
05/03/2012WO2012058636A1 Modified valencene synthase polypeptides, encoding nucleic acid molecules and uses thereof
05/03/2012WO2012058634A2 Epigenomic induced pluripotent stem cell signatures
05/03/2012WO2012058616A2 Engineered kinetochores and uses thereof
05/03/2012WO2012058588A2 Novel egfr-binding molecules and immunoconjugates thereof
05/03/2012WO2012058528A2 Drought tolerant plants and related constructs and methods involving genes encoding dtp6 polypeptides
05/03/2012WO2012058522A2 Cancer imaging with therapy: theranostics
05/03/2012WO2012058493A2 Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
05/03/2012WO2012058458A2 Method for increasing the efficiency of double-strand break-induced mutagenesis
05/03/2012WO2012058363A2 Recombinant envelope protein of human immunodeficiency virus (hiv) and vaccine containing the same
05/03/2012WO2012058303A2 Rapid salmonella serotyping assay
05/03/2012WO2012058268A2 Treatment of interferon-related developmental regulator 1 (ifrd1) related diseases by inhibition of natural antisense transcript to ifrd1
05/03/2012WO2012058266A1 Overexpression of plant mirnas for parasite control
05/03/2012WO2012058243A2 Cell fate conversion of differentiated somatic cells into glial cells
05/03/2012WO2012058223A1 Transgenic plants having altered biomass composition
05/03/2012WO2012058220A2 Anti-sod1 antibodies and uses thereof
05/03/2012WO2012058201A2 Method for determining activators of excitatory synapse formation
05/03/2012WO2012058073A2 Methods and compositions to protect aquatic invertebrates from disease
05/03/2012WO2012058072A1 Method of rapidly producing vaccines for animals
05/03/2012WO2012057671A1 New compositions and methods for treatment of autoimmune and allergic diseases
05/03/2012WO2012057640A1 A plant homolog to autophagy protein p62
05/03/2012WO2012057591A2 Resistance gene to xanthomonas axonopodis in soybeans
05/03/2012WO2012057567A2 Kit for screening for skin-activating substances and comprising the klotho gene, and method for screening for skin-activating substances using same
05/03/2012WO2012057529A2 Method for purifying human granulocyte-colony stimulating factor from recombinant e. coli
05/03/2012WO2012057527A2 Method for mass production of factor vii/viia
05/03/2012WO2012057466A2 Salt tolerance sydbsp gene derived from synechocystis, and uses thereof
05/03/2012WO2012057465A2 Salt tolerance sygt gene derived from synechocystis, and uses thereof
05/03/2012WO2012057436A1 Composition for phytochelatin transport
05/03/2012WO2012057421A1 Cancer-metastasis suppression by means of increased task-3 potassium channel expression
05/03/2012WO2012057396A1 Yeast expression vector for chromosomal integration, and use thereof
05/03/2012WO2012057363A1 Adeno-associated virus virions for transferring genes into neural cells
05/03/2012WO2012057361A1 Method for increasing plant biomass by controlling express the amount of activated cytokinin
05/03/2012WO2012057328A1 Anti-cdh3 antibody having high internalizing capability
05/03/2012WO2012057315A1 High-affinity anti-cdh3 antibody
05/03/2012WO2012057288A1 Novel anti-dr5 antibody
05/03/2012WO2012057052A1 Use of peptidyl-prolyl isomerase pin1 for controlling stable maintenance and renewal of stem cells
05/03/2012WO2012056811A1 Method for selecting fungus body and kit
05/03/2012WO2012056694A1 Method for assessing breast cancer susceptibility
05/03/2012WO2012056683A1 METHOD FOR PRODUCING cAMP USING CHIMERIC OLFACTORY RECEPTOR
05/03/2012WO2012056603A1 METHOD FOR PRODUCING cAMP USING CHIMERIC OLFACTORY RECEPTOR
05/03/2012WO2012056441A1 Compositions and methods for specific cleavage of exogenous rna in a cell
05/03/2012WO2012056401A1 ISOLATED POLYNUCLEOTIDES EXPRESSING OR MODULATING MICRORNAs OR TARGETS OF SAME, TRANSGENIC PLANTS COMPRISING SAME AND USES THEREOF IN IMPROVING NITROGEN USE EFFICIENCY, ABIOTIC STRESS TOLERANCE, BIOMASS, VIGOR OR YIELD OF A PLANT
05/03/2012WO2012056056A1 Transgenic trees having a greater quantity of biomass and carbohydrates
05/03/2012WO2012056048A1 Treatment of inflammation
05/03/2012WO2012055982A2 Down-regulating gene expression in insect pests
05/03/2012WO2012055962A1 Gene conferring tobacco streak virus resistance
05/03/2012WO2012055904A1 Temperature-stable ss-pyranosidase
05/03/2012WO2012055891A1 Murine model of inflammation with il33 n-terminal domain deletion
05/03/2012WO2012055880A1 Method of treatment based on atad2 inhibitors
05/03/2012WO2012055879A1 Method of treatment by inhibition of baz1b